Jamie Clark
Stock Analyst at Rothschild & Co
(2.61)
# 2,102
Out of 5,115 analysts
9
Total ratings
71.43%
Success rate
13.76%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jamie Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Buy | $311 | $231.12 | +34.56% | 1 | Sep 15, 2025 | |
| MEDP Medpace Holdings | Downgrades: Neutral | $342 → $474 | $582.48 | -18.62% | 1 | Sep 3, 2025 | |
| ICLR ICON Public Limited Company | Upgrades: Buy | $184 → $236 | $180.25 | +30.93% | 1 | Sep 3, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $188 → $182 | $210.48 | -13.53% | 3 | May 23, 2025 | |
| LH Labcorp Holdings | Initiates: Buy | $276 | $271.52 | +1.65% | 1 | Apr 2, 2025 | |
| DGX Quest Diagnostics | Initiates: Buy | $195 | $187.03 | +4.26% | 1 | Apr 2, 2025 | |
| IQV IQVIA Holdings | Initiates: Buy | $276 | $230.15 | +19.92% | 1 | Oct 14, 2024 |
West Pharmaceutical Services
Sep 15, 2025
Initiates: Buy
Price Target: $311
Current: $231.12
Upside: +34.56%
Medpace Holdings
Sep 3, 2025
Downgrades: Neutral
Price Target: $342 → $474
Current: $582.48
Upside: -18.62%
ICON Public Limited Company
Sep 3, 2025
Upgrades: Buy
Price Target: $184 → $236
Current: $180.25
Upside: +30.93%
Charles River Laboratories International
May 23, 2025
Upgrades: Buy
Price Target: $188 → $182
Current: $210.48
Upside: -13.53%
Labcorp Holdings
Apr 2, 2025
Initiates: Buy
Price Target: $276
Current: $271.52
Upside: +1.65%
Quest Diagnostics
Apr 2, 2025
Initiates: Buy
Price Target: $195
Current: $187.03
Upside: +4.26%
IQVIA Holdings
Oct 14, 2024
Initiates: Buy
Price Target: $276
Current: $230.15
Upside: +19.92%